Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ).
about
Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid ArthritisSubcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.Quality of life of early stage colorectal cancer patients in Morocco.Forum for injection techniques, India: the first Indian recommendations for best practice in insulin injection techniqueResults of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis.Secukinumab: a promising therapeutic option in spondyloarthritis.Using Patient Feedback to Optimize the Design of a Certolizumab Pegol Electromechanical Self-Injection Device: Insights from Human Factors Studies.Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment.A novel electromechanical autoinjector, AutoTouch™, for self-injection of etanercept: real-world use and benefits.Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis.Evaluation of performance, acceptance, and compliance of an auto-injector in healthy and rheumatoid arthritic subjects measured by a motion capture system.Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3).Secukinumab administration by autoinjector maintains reduction of plaque psoriasis severity over 52 weeks: results of the randomized controlled JUNCTURE trial.Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE).Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE).
P2860
Q33725535-4DADB11A-4171-47E0-8489-D77CBFCBF63FQ34036038-D62F8D30-5DC9-4310-B3D1-50DCF9688EC5Q36161731-D9226450-8A29-4999-BB3D-0E56D5E53DCEQ36436481-55EE2D33-6E37-47FD-A162-1FD69742DBF3Q37597518-6DA81DF8-651A-4889-B2CB-B0997932A24FQ38903129-81977F7F-05BA-496F-8727-1E503CEE63FBQ47266821-5B739DED-96AF-4E6C-89AE-A2952ED32617Q47624105-7A31C1AF-1237-45DD-ABB7-4EB8FE9F2FFCQ51103736-A3FBD0FF-2461-4335-87FE-4BBFC8B0021FQ51113975-9FD2C054-0580-4CCA-AE40-896E291EB580Q52576324-A53D71C4-304F-4F42-94CA-4EE378E8957FQ52653700-AE48EF63-81FD-404E-912D-55C7084F3445Q52922335-516C7B03-19E4-4FAC-AC0B-918C50C70E5AQ53438409-09F6BDF9-FF05-470C-9135-3063BE69E8D1Q53471047-E1B494CA-1886-4FAA-8D7A-5C5BD687C51B
P2860
Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ).
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Assessment of self-injection e ...... sessment Questionnaire (SIAQ).
@ast
Assessment of self-injection e ...... sessment Questionnaire (SIAQ).
@en
Assessment of self-injection e ...... ction Assessment Questionnaire
@nl
type
label
Assessment of self-injection e ...... sessment Questionnaire (SIAQ).
@ast
Assessment of self-injection e ...... sessment Questionnaire (SIAQ).
@en
Assessment of self-injection e ...... ction Assessment Questionnaire
@nl
prefLabel
Assessment of self-injection e ...... sessment Questionnaire (SIAQ).
@ast
Assessment of self-injection e ...... sessment Questionnaire (SIAQ).
@en
Assessment of self-injection e ...... ction Assessment Questionnaire
@nl
P2860
P356
P1476
Assessment of self-injection e ...... sessment Questionnaire (SIAQ).
@en
P2093
Dorothy Keininger
Geoffroy Coteur
P2860
P2888
P356
10.1186/1477-7525-9-2
P577
2011-01-13T00:00:00Z